We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.2B
AUM Growth
-$235M
Cap. Flow
-$283M
Cap. Flow %
-1.55%
Top 10 Hldgs %
32.02%
Holding
333
New
17
Increased
37
Reduced
36
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 28.16%
2 Technology 19.07%
3 Financials 13.73%
4 Industrials 8.28%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BX icon
26
Blackstone
BX
$110B
$261M 1.43%
3,114,951
+293,500
+10% +$28.4M
DT icon
27
Dynatrace
DT
$14.2B
$251M 1.38%
7,202,000
-645,000
-8% -$24.9M
META icon
28
Meta Platforms (Facebook)
META
$1.51T
$245M 1.35%
1,807,040
+26,000
+1% +$4.21M
SJR
29
DELISTED
Shaw Communications Inc.
SJR
$226M 1.24%
9,302,000
-615,000
-6% -$16.3M
NYT icon
30
New York Times
NYT
$10.2B
$225M 1.24%
7,828,073
+947,269
+14% +$29M
SPGI icon
31
S&P Global
SPGI
$120B
$219M 1.2%
717,500
+388,500
+118% +$139M
AON icon
32
Aon
AON
$76B
$217M 1.19%
808,486
-120,000
-13% -$33.9M
CSGP icon
33
CoStar Group
CSGP
$12.3B
$206M 1.13%
2,960,185
-2,003,000
-40% -$139M
IBB icon
34
PUT
iShares Biotechnology ETF
IBB
$9.77B
$199M 1.09%
+1,700,000
New +$211M
ADBE icon
35
Adobe
ADBE
$105B
$191M 1.05%
694,772
-16,000
-2% -$6.05M
NOW icon
36
ServiceNow
NOW
$129B
$186M 1.02%
2,467,750
+17,000
+0.7% +$1.53M
BEKE icon
37
KE Holdings
BEKE
$18.8B
$174M 0.96%
9,958,500
BEAM icon
38
Beam Therapeutics
BEAM
$2.84B
$173M 0.95%
3,631,271
+159,000
+5% +$9.07M
EXEL icon
39
Exelixis
EXEL
$13.4B
$167M 0.92%
10,675,844
+501,571
+5% +$9.69M
XYZ
40
Block Inc
XYZ
$47.5B
$142M 0.78%
2,584,000
-255,000
-9% -$18.1M
VMW
41
DELISTED
VMware, Inc
VMW
$125M 0.69%
1,175,623
+165,623
+16% +$19.1M
HUM icon
42
Humana
HUM
$46.2B
$122M 0.67%
+251,200
New +$122M
CVS icon
43
CVS Health
CVS
$122B
$120M 0.66%
1,256,259
+10,000
+0.8% +$990K
UTHR icon
44
United Therapeutics
UTHR
$23.1B
$115M 0.63%
549,673
+156,977
+40% +$35.1M
HZNP
45
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$110M 0.61%
1,780,223
+687,063
+63% +$48M
LHCG
46
DELISTED
LHC Group LLC
LHCG
$106M 0.58%
650,000
+360,000
+124% +$58.4M
ABBV icon
47
AbbVie
ABBV
$435B
$97.3M 0.53%
725,112
+219,597
+43% +$31.5M
SWCH
48
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$88.6M 0.49%
2,630,000
+300,000
+13% +$10.2M
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$29.3B
$85.8M 0.47%
428,456
-359,454
-46% -$68.6M
INSP icon
50
Inspire Medical Systems
INSP
$1.74B
$85.5M 0.47%
481,996
+68,996
+17% +$13.9M

Similar funds

Farallon Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Farallon Capital Management held 333 positions worth $18.2B, down 1.3% from $18.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Farallon Capital Management's Q3 2022 filing shows 17 new, 37 increased, 36 reduced and 22 closed positions. Its largest new stake was Humana: 251,200 shares worth $122M. The largest sale was Coherent Inc, an estimated $154M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q3 2022 buy was Humana: 251,200 shares worth $122M.
  • Farallon Capital Management added most to ZENDESK INC in Q3 2022, an estimated $262M increase.
  • Farallon Capital Management's biggest Q3 2022 reduction was Howmet Aerospace, cutting an estimated $140M.
  • Farallon Capital Management fully exited Coherent Inc in Q3 2022, selling an estimated $154M.
  • Farallon Capital Management's ten largest holdings make up 32% of its $18.2B portfolio in Q3 2022.
  • Farallon Capital Management opened 17 new positions and closed 22 in Q3 2022.
  • Farallon Capital Management's portfolio value fell 1.3% quarter-over-quarter to $18.2B.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.